Published in Blood Transfus on July 01, 2009
Global trends in emerging infectious diseases. Nature (2008) 23.66
Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet (2007) 10.81
The challenge of emerging and re-emerging infectious diseases. Nature (2004) 8.94
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Infectious history. Science (2000) 6.09
The 1918 influenza pandemic: insights for the 21st century. J Infect Dis (2007) 4.99
Social and environmental risk factors in the emergence of infectious diseases. Nat Med (2004) 4.33
Resurgent vector-borne diseases as a global health problem. Emerg Infect Dis (1998) 4.20
Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol (2004) 4.13
Update: infections with a swine-origin influenza A (H1N1) virus--United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep (2009) 3.36
Changing patterns of infectious disease. Nature (2000) 3.21
The origins of acquired immune deficiency syndrome viruses: where and when? Philos Trans R Soc Lond B Biol Sci (2001) 3.10
Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol (2006) 2.95
Climatic and environmental patterns associated with hantavirus pulmonary syndrome, Four Corners region, United States. Emerg Infect Dis (1999) 2.73
SARS--beginning to understand a new virus. Nat Rev Microbiol (2003) 2.30
Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc Natl Acad Sci U S A (1994) 2.05
Infectious diseases: considerations for the 21st century. Clin Infect Dis (2001) 1.75
Molecular constraints to interspecies transmission of viral pathogens. Nat Med (2004) 1.56
Ecology of Marburg and Ebola viruses: speculations and directions for future research. J Infect Dis (1999) 1.48
Geography, ecology and emerging infectious diseases. Soc Sci Med (2000) 1.46
A review of studies on animal reservoirs of the SARS coronavirus. Virus Res (2007) 1.32
West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. Blood Transfus (2008) 1.29
From Pasteur to genomics: progress and challenges in infectious diseases. Nat Med (2004) 1.27
Update: outbreak of severe acute respiratory syndrome--worldwide, 2003. MMWR Morb Mortal Wkly Rep (2003) 0.98
Detection of West Nile virus in blood donations--United States, 2003. MMWR Morb Mortal Wkly Rep (2003) 0.87
Tickborne encephalitis virus, northeastern Italy. Emerg Infect Dis (2006) 0.81
Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet (2005) 2.95
Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol (2004) 2.58
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis (2010) 1.74
Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology (2004) 1.70
Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine (2007) 1.53
Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis (2010) 1.47
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine (2005) 1.46
Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy. Transfusion (2002) 1.32
Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion (2008) 1.20
Safety and immunogenicity of influenza vaccination in individuals infected with HIV. Vaccine (2002) 1.12
Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine (2007) 1.11
Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol (2003) 1.09
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic. PLoS One (2011) 1.04
High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping. J Med Virol (2012) 1.02
Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 0.98
Development of a seven-target multiplex PCR for the simultaneous detection of transgenic soybean and maize in feeds and foods. J Agric Food Chem (2004) 0.96
Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level. Vaccine (2012) 0.95
Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAMA (2010) 0.95
Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS One (2013) 0.94
Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern Italy. Infect Genet Evol (2012) 0.94
Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. Vaccine (2011) 0.92
Hepatitis A, Italy. Emerg Infect Dis (2005) 0.92
Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma. J Med Virol (2005) 0.91
Pandemic influenza vaccine in adult HIV-1-infected patients. AIDS (2010) 0.91
The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine (2009) 0.90
Virtual quantification of influenza A virus load by real-time RT-PCR. J Clin Virol (2012) 0.89
Pertussis. Hum Vaccin Immunother (2014) 0.88
Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. J Clin Virol (2006) 0.88
Rapid molecular evolution of human bocavirus revealed by Bayesian coalescent inference. Infect Genet Evol (2009) 0.88
Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J Med Virol (2007) 0.87
Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine (2009) 0.87
Reconstruction of the evolutionary dynamics of the A(H1N1)pdm09 influenza virus in Italy during the pandemic and post-pandemic phases. PLoS One (2012) 0.86
Detection and quantitation of hepatitis E virus in human faeces by real-time quantitative PCR. J Virol Methods (2004) 0.86
Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis. Vaccine (2002) 0.86
An economic evaluation of varicella vaccination in Italian adolescents. Vaccine (2004) 0.85
Development of a peptide nucleic acid array platform for the detection of genetically modified organisms in food. J Agric Food Chem (2005) 0.85
Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women. J Hepatol (2005) 0.85
Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy. Vaccine (2012) 0.85
Outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016. Euro Surveill (2016) 0.84
Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy. BMC Infect Dis (2010) 0.83
Epidemiological and clinical features of respiratory viral infections in hospitalized children during the circulation of influenza virus A(H1N1) 2009. Influenza Other Respir Viruses (2011) 0.83
Occult hepatitis B in blood donors: a description of two cases. Blood Transfus (2010) 0.83
Hepatitis E and lymphocytic leukemia in Man, Italy. Emerg Infect Dis (2013) 0.83
Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment. J Med Virol (2006) 0.82
Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. Clin Vaccine Immunol (2011) 0.81
Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group. Blood Transfus (2011) 0.81
Ten years (2004-2014) of influenza surveillance in Northern Italy. Hum Vaccin Immunother (2014) 0.81
Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza. Vaccine (2010) 0.80
Human papillomavirus genotypes and anal-related lesions among HIV-1-infected men in Milan, Italy. J Acquir Immune Defic Syndr (2008) 0.80
Surveillance of influenza viruses in the post-pandemic era (2010-2012) in Northern Italy. Hum Vaccin Immunother (2013) 0.80
Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Vaccine (2007) 0.80
Surveillance of acute flaccid paralysis (AFP) in Lombardy, Northern Italy, from 1997 to 2011 in the context of the national AFP surveillance system. Hum Vaccin Immunother (2014) 0.80
Anal HPV genotypes and related displasic lesions in Italian and foreign born high-risk males. Vaccine (2009) 0.80
Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Vaccine (2009) 0.80
Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users. Addiction (2004) 0.79
Co-circulation of genetically distinct human metapneumovirus and human bocavirus strains in young children with respiratory tract infections in Italy. J Med Virol (2011) 0.79
Human papillomavirus genotypes and phylogenetic analysis of HPV-16 variants in HIV-1 infected subjects in Italy. Vaccine (2009) 0.79
Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users. Drug Alcohol Depend (2004) 0.79
Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy. J Med Virol (2006) 0.79
Clinical, epidemiological and virological features of acute hepatitis B in Italy. Infection (2015) 0.78
Two cases of neonatal human parechovirus 3 encephalitis. Pediatr Infect Dis J (2014) 0.78
Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus. J Med Virol (2003) 0.78
Transfusion of red blood cells from an HIV-RNA-positive/anti-HIV-negative donor without HIV infection in the recipient. Transfusion (2007) 0.78
Molecular characterization of influenza viruses circulating in Northern Italy during two seasons (2005/2006 and 2006/2007) of low influenza activity. J Med Virol (2008) 0.77
Surveillance of hepatitis A virus in urban sewages and comparison with cases notified in the course of an outbreak, Italy 2013. BMC Infect Dis (2014) 0.77
Surveillance and vaccination coverage of measles and rubella in Northern Italy. Hum Vaccin Immunother (2014) 0.75
Viable Newcastle disease vaccine strains in a pharmaceutical dump. Emerg Infect Dis (2007) 0.75
Multiple clusters of A(H1N1)pdm09 virus circulating in severe cases of influenza during the 2010-2011 season: a phylogenetic and molecular analysis of the neuraminidase gene. J Med Virol (2013) 0.75